Derma Sciences (DSCI) Tops Q4 EPS by 3c

Derma Sciences (NASDAQ: DSCI) reported Q4 EPS of ($0.36), $0.03 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $20.3 million versus the consensus estimate of $20.21 million.

For earnings history and earnings-related data on Derma Sciences (DSCI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49